DAILEY ROBERT JACKMAN
Related Filers (1)
Ownership (19)
3
Monday, 6/7/2021
Immune Therapeutics, Inc.: Initial statement of beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Friday, 3/30/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Thursday, 3/29/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Thursday, 3/29/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Thursday, 3/29/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Wednesday, 3/28/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Wednesday, 3/28/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Wednesday, 3/28/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 6/2/2015
Immune Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 12/10/2014
Immune Therapeutics, Inc.: Major Shareholders